Judgment Kanavape: CBD Is Not a Narcotic Drug

On November 19, 2020, the Court of Justice of the European Union ruled in Case C-663/18 (Kanavape), establishing a fundamental doctrine: CBD extracted from the cannabis plant is NOT a narcotic drug and should therefore benefit from the free movement of goods in the EU.

The Kanavape Doctrine in one sentence:

A Member State may not prohibit the marketing of CBD legally produced in another Member State when it is extracted from the Cannabis sativa plant in its entirety.

The Case

The French company Kanavape marketed electronic cigarettes with CBD oil extracted from hemp flowers legally grown in the Czech Republic. The French authorities prosecuted its managers on the grounds that CBD was a narcotic drug.

C-663/18

Case number

EU Court of Justice

19/11/2020

Sentence date

Binding doctrine

✦

The Doctrine of the TJUE

1. The CBD Is Not a Narcotic Drug

"
The CBD in question does not appear to have psychotropic or harmful effects on human health based on the available scientific data.
— TJUESentencia C-663/18, 2020

The Tribunal concluded that:

The CBD is not included in the 1961 Single Convention
It does not have the psychotropic effects of THC
The scientific data do not demonstrate danger

2. The Origin Is Irrelevant

Fundamental Principle

It does not matter whether the CBD comes from flowers or other parts of the plant. What is relevant is the substance itself, not its botanical origin.

3. Free Movement of Goods

The CBD, not being a narcotic drug, is protected by the Treaty on the Functioning of the European Union (TFEU).

Gavel of justice and EU flags — Any restriction on free movement must be fully justified by real health risks, not mere assumptions.
📷 AECANI Visual Lab

Burden of Proof

A State wishing to restrict the circulation of CBD must scientifically prove that there is a real health risk. Mere suspicion is not enough.

Implications for Spain

The Kanavape judgment has direct effects for the Spanish legal system:

The CBD cannot be considered a narcotic drug per se
Products with legal CBD in another Member State must be able to move freely
Restrictions must be scientifically justified

Aspects to Consider

The Spanish framework presents aspects that may require harmonization with the Kanavape doctrine. Legal CBD products in other Member States could benefit from greater regulatory clarity.

📚 References

TJUE (2020) - Ruling C-663/18, Kanavape (November 19, 2020)
Single Convention on Narcotic Drugs (1961) - United Nations
TFEU - Articles 34-36 on free movement of goods